Mounjaro brought in $10.7 billion and Zepbound $5.4 billion in Q3. Lilly also reported retatrutide Phase 3 data showing 20.9% weight loss versus 9.4% on Ozempic.
Recap by typeshit. Full story at BigGo Finance.
BuzzFeed notes these medications have helped people worldwide, pro athletes among them, with weight, appetite and blood sugar control.
Novo Nordisk's weight loss drug brand is the presenting sponsor of the playoff game, airing at 4:30 PM ET on TSN, RDS and CFL+.
Novo Nordisk's Wegovy puts its name on the October 31 playoff game in Canada, airing at 4:30 PM ET on TSN, RDS and CFL+.
A doctor writes about a 45-year-old woman without diabetes who came in for obesity treatment, opening a column on how such patients are handled.
Lilly shares jumped 6% to a record high Thursday after earnings beat expectations, with weight loss drug sales leading the way.
A short social clip walking through one day of meals on Wegovy. No further detail is given beyond the food diary format.
Loading…